MIT Technology Review @techreview
In a bid to treat ultra-rare genetic diseases, some parents are embarking on multimillion-dollar quests to finance experimental gene therapies—and designating their own children as the first recipients. https://t.co/156fECQAtc — PolitiTweet.org